Progressive Care, Inc.
RXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $49,727 | $40,602 | $38,853 | $38,938 |
| % Growth | 22.5% | 4.5% | -0.2% | – |
| Cost of Goods Sold | $34,565 | $30,899 | $28,679 | $29,970 |
| Gross Profit | $15,162 | $9,703 | $10,174 | $8,968 |
| % Margin | 30.5% | 23.9% | 26.2% | 23% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,554 | $11,985 | $11,210 | $9,978 |
| SG&A Expenses | $13,686 | $12,285 | $11,210 | $9,978 |
| Sales & Mktg Exp. | $4,679 | $300 | $0 | $0 |
| Other Operating Expenses | $29,181 | -$2,079 | $0 | $0 |
| Operating Expenses | $32,684 | $10,206 | $11,210 | $9,984 |
| Operating Income | -$124 | -$503 | -$1,036 | -$1,016 |
| % Margin | -0.2% | -1.2% | -2.7% | -2.6% |
| Other Income/Exp. Net | -$19,291 | -$3,324 | $1,463 | -$296 |
| Pre-Tax Income | -$19,415 | -$5,903 | $218 | -$1,443 |
| Tax Expense | -$4,767 | $1 | $0 | $7 |
| Net Income | -$14,648 | -$5,904 | -$1,178 | -$1,450 |
| % Margin | -29.5% | -14.5% | -3% | -3.7% |
| EPS | -2.36 | -2.03 | -0.45 | -0.63 |
| % Growth | -16.3% | -351.1% | 28.6% | – |
| EPS Diluted | -2.36 | -2.03 | -0.38 | -0.63 |
| Weighted Avg Shares Out | 6,196 | 2,912 | 2,603 | 2,311 |
| Weighted Avg Shares Out Dil | 6,196 | 2,912 | 3,090 | 2,311 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $85 | $0 | $0 |
| Interest Expense | $0 | $798 | $1,396 | $1,703 |
| Depreciation & Amortization | $1,600 | $361 | $534 | $822 |
| EBITDA | $1,476 | -$1,867 | -$468 | -$163 |
| % Margin | 3% | -4.6% | -1.2% | -0.4% |